168 related articles for article (PubMed ID: 11354564)
1. Pulmonary function tests, high-resolution computerized tomography, alpha1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis.
Shahin AA; Sabri YY; Mostafa HA; Sabry EY; Hamid MA; Gamal H; Shahin HA
Rheumatol Int; 2001 Apr; 20(3):95-100. PubMed ID: 11354564
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
[TBL] [Abstract][Full Text] [Related]
3. HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis.
Panigada S; Ravelli A; Silvestri M; Granata C; Magni-Manzoni S; Cerveri I; Dore R; Tomà P; Martini A; Rossi GA; Sacco O
Pediatr Pulmonol; 2009 Dec; 44(12):1226-34. PubMed ID: 19911363
[TBL] [Abstract][Full Text] [Related]
4. HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.
Bellia M; Cannizzaro F; Scichilone N; Riili M; Triolo G; Midiri M; Lagalla R
Radiol Med; 2009 Mar; 114(2):190-203. PubMed ID: 19266260
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
7. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
[TBL] [Abstract][Full Text] [Related]
8. High resolution computed tomography in early scleroderma lung disease.
Warrick JH; Bhalla M; Schabel SI; Silver RM
J Rheumatol; 1991 Oct; 18(10):1520-8. PubMed ID: 1765976
[TBL] [Abstract][Full Text] [Related]
9. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography.
Zompatori M; Leone MB; Giannotta M; Galiè N; Palazzini M; Reggiani ML; Bono L; Pollini GS
Radiol Med; 2013 Dec; 118(8):1360-72. PubMed ID: 23716290
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
13. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease in systemic sclerosis.
Ooi GC; Mok MY; Tsang KW; Wong Y; Khong PL; Fung PC; Chan S; Tse HF; Wong RW; Lam WK; Lau CS
Acta Radiol; 2003 May; 44(3):258-64. PubMed ID: 12751995
[TBL] [Abstract][Full Text] [Related]
15. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis.
Pandey AK; Wilcox P; Mayo JR; Sin D; Moss R; Ellis J; Brown J; Leipsic J
Can Assoc Radiol J; 2010 Dec; 61(5):291-6. PubMed ID: 20382500
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis: using high-resolution CT to detect lung disease in children.
Seely JM; Jones LT; Wallace C; Sherry D; Effmann EL
AJR Am J Roentgenol; 1998 Mar; 170(3):691-7. PubMed ID: 9490955
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
18. Quantitative chest CT analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests.
Kloth C; Maximilian Thaiss W; Preibsch H; Mark K; Kötter I; Hetzel J; Nikolaou K; Henes J; Horger M
Rheumatology (Oxford); 2016 Oct; 55(10):1763-70. PubMed ID: 27330164
[TBL] [Abstract][Full Text] [Related]
19. Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center.
Arakkal G; Chintagunta SR; Chandika V; Damarla SV; Manchala S; Kumar BU
Indian J Dermatol Venereol Leprol; 2017; 83(6):677-682. PubMed ID: 29035287
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
